Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 74 results found. Search for [ IPCA ]

Results 1 to 21 of 74
BusinessToday.In
New Delhi, March 26, 2020
A global hunt is on to find the right medicine for coronavirus. Leading Indian companies such as IPCA, Zydus Cadila are manufacturing anti-rheumatoid arthritis drugs like hydroxychloroquine and anti-malaria medicine like chloroquine. The demand for hydroxychloroquine and chloroquine jumped after US President Donald Trump called them effective in treating COVID-19. The Indian Council of Medical Research (ICMR) had also recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases. The Indian manufacturers have, however, reassured that there is enough capacity to meet the demand. Watch the video for more.Also Read: Hand sanitiser demand grows 1425%, face-mask 408% in February-March: Nielsen


E Kumar Sharma
New Delhi, March 25, 2020
Leading Indian companies such as IPCA, Zydus Cadila are manufacturing anti-rheumatoid arthritis drugs like hydroxychloroquine and anti-malaria medicine like chloroquine. Cipla and Aurobindo are making anti-HIV medicines


BusinessToday.In
March 23, 2020
Pharmaceutical company Ipca Laboratories share price reportedly rose over 12 per cent after the US Food and Drug Administration (USFDA) partially allowed import of chloroquine


Aseem Thapliyal
March 23, 2020
Sensex lost 2,991 points or 10% which led to the triggering of circuit breaker on BSE and NSE. Nifty too declined  9.40% or 822 points to 7,923 in early trade


BusinessToday.In
March 23, 2020
Sensex, Nifty Live News: During the session, Sensex hit an intraday low of 25,880 and Nifty fell to 7,583. All Sensex and Nifty stocks closed in the red


BusinessToday.In
February 14, 2020
Share Market Update: BSE 30-share S&P Sensex ended 202 points lower at 41,257 and NSE 50-share index Nifty50 closed 61 points lower at 12,113.


BusinessToday.In
February 12, 2020
Share Market Update: IRCTC, P&G Hygiene, Ashok Leyland, Torrent Power, Suzlon Energy among others will announce their Q3 results today


BusinessToday.In
February 11, 2020
Stocks to watch today on February 12: IRCTC, P&G Hygiene, Ashok Leyland, City Union Bank, Torrent Power, Suzlon, Hindalco, BHEL, IDBI Bank, Aster DM Healthcare, Glenmark Pharmaceuticals, IndusInd Bank among others are the top stocks to watch out for in Wednesday's trading session


BusinessToday.In
January 23, 2020
Stocks to watch today on January 24: Bank of Baroda, Indian Bank, Ultratech Cement, HDFC Life, PNB Housing among others are the top stocks to watch out for in Friday's trading session


BusinessToday.In
November 7, 2019
Benchmark indices climbed to record high levels gaining 0.40% each by the closing bell today, backed by strong global equities after China said it agreed with the US to roll back tariffs imposed during their prolonged trade war. While Sensex made its highest closing at 40,653, Nifty ended above 12K mark at 12,016 for the first time after June 2019, backed by gains in industry heavyweight HDFC.Top Nifty gainers included Sun Pharma, IndusInd Bank, Bharti Infratel, Hindalco Industries and JSW St...


BusinessToday.In
October 30, 2019
Ajanta Pharma share price which stood at Rs 12.41 on October 30, 2009 has risen to Rs 1,020 during the period.


PTI
October 17, 2019



PTI
October 2, 2019



PTI
October 2, 2019



BusinessToday.In
May 29, 2019
Except IT sector, all the other indices ended in the red in today's trade. Biggest fall in today's trade was seen in PSU Bank, which was down 2.8%, followed by Auto, Media, Infra, Energy and Metal, each declining over 1%. Only gaining sector of the day was IT, up 0.66%.


PTI
New Delhi, May 26, 2019
The states had to submit action plans by April 30 to the CPCB, failing which they would have to pay the pollution body a compensation at the rate of Rs one crore per month, as per the National Green Tribunal (NGT) order


PTI
May 26, 2019



PTI
April 24, 2019



PTI
October 3, 2018



E Kumar Sharma
New Delhi, June 13, 2018
The development is a hugely positive development both for Sun Pharma and for Indian pharma. From a sentiment perspective, it is significant given that the company has been finally able to get its facility cleared after three years.


PAGES 1 OF 4  1234